Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Iressa Versus Docetaxel (Taxotere)

This study has been completed.
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00076388
First received: January 21, 2004
Last updated: May 12, 2011
Last verified: May 2011